FTSE All-Share
4.421,29
PKT
-9,84
PKT
-0,22
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.11.24 | HSBC Equal Weight | Barclays Capital | |
| 19.11.24 | Rio Tinto Neutral | UBS AG | |
| 18.11.24 | BP Buy | Goldman Sachs Group Inc. | |
| 15.11.24 | GSK Hold | Deutsche Bank AG | |
| 15.11.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 15.11.24 | BP Buy | Jefferies & Company Inc. | |
| 15.11.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 14.11.24 | Vodafone Group Halten | DZ BANK | |
| 14.11.24 | National Grid Buy | UBS AG | |
| 14.11.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 13.11.24 | AstraZeneca Halten | DZ BANK | |
| 13.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 13.11.24 | Vodafone Group Buy | Deutsche Bank AG | |
| 13.11.24 | Vodafone Group Equal Weight | Barclays Capital | |
| 13.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | HSBC Sector Perform | RBC Capital Markets | |
| 12.11.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 12.11.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | AstraZeneca Sell | UBS AG | |
| 12.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | Vodafone Group Neutral | UBS AG | |
| 12.11.24 | Vodafone Group Underperform | Bernstein Research | |
| 12.11.24 | GSK Hold | Jefferies & Company Inc. | |
| 11.11.24 | National Grid Outperform | RBC Capital Markets | |
| 08.11.24 | National Grid Buy | Deutsche Bank AG | |
| 08.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 08.11.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 08.11.24 | BP Underweight | JP Morgan Chase & Co. | |
| 08.11.24 | National Grid Buy | Goldman Sachs Group Inc. | |
| 07.11.24 | National Grid Overweight | JP Morgan Chase & Co. | |
| 07.11.24 | National Grid Buy | UBS AG | |
| 07.11.24 | National Grid Outperform | RBC Capital Markets | |
| 07.11.24 | AstraZeneca Sell | UBS AG | |
| 07.11.24 | National Grid Buy | Goldman Sachs Group Inc. | |
| 07.11.24 | National Grid Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 06.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Sell | UBS AG |